Table 3. PBMC respiration (high-resolution respirometry) and muscle de- and re-oxygenation (NIRS) before and after training.
|
|
O2 flow corrected for Rox |
Overall sprinting |
O2 flux corrected for Rox |
Repeated sprinting |
IO2 [amol·s-1·cell-1] |
∆ De-oxygenation |
∆ Re-oxygenation |
JO2/CS [pmol·s-1·IU-1] |
∆ Re-oxygenation |
before |
after |
∆ |
TOI [%] |
TOI [%] |
before |
after |
∆ |
[TOI%] |
RSH 1 |
R |
5.1 |
4.0 |
|
|
|
1.17 |
1.31 |
|
|
E |
23.4 |
13.7 |
-9.7 |
-9.7 |
12.82 |
5.39 |
4.43 |
-0.96 |
-2.9 |
RSH 2 |
R |
3.6 |
3.0 |
|
|
|
0.93 |
0.94 |
|
|
|
E |
21.4 |
8.0 |
-13.4 |
-19.8 |
12.4 |
5.54 |
2.48 |
-3.06 |
5.8 |
SIH 1 |
R |
2.9 |
4.9 |
|
|
|
1.08 |
1.37 |
|
|
|
E |
16.8 |
16.0 |
-0.7 |
-2.3 |
7.7 |
6.34 |
4.49 |
-1.86 |
2.9 |
SIH 2 |
R |
3.3 |
5.5 |
|
|
|
1.13 |
1.26 |
|
|
|
E |
18.4 |
23.5 |
5.1 |
1.24 |
-0.44 |
6.24 |
5.36 |
-0.88 |
-1.84 |
RSH1, RSH2 – participants with RSH training, SIH1, SIH2 – participants with SIH training. ROUTINE respiration (R) and electron transfer capacity (E) were determined as described in the methods section. I
O2 – oxygen flow per cell count [amol·s
-1·cell
-1 = pmol·s
-1·10
-6 cells], J
O2 – oxygen flux per mitochondrial marker citrate synthase activity [pmol·s
-1·IU
-1]
37. Respiration was corrected for the contribution from PLTs contaminating the PBMC fraction. Rox – residual oxygen consumption.